Cancer drug dramatically shrinks prostate tumors in study

The survival rate more than doubles among most of the men with aggressive cancers in limited trial. A second, wider test shows similar promising results. 'Spectacularly effective,' a researcher says. An experimental cancer drug shrank prostate tumors dramatically and more than doubled survival in 70% to 80% of patients with aggressive cancers, British researchers reported today.

Read the whole article

See latest science articles from LA Times - Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox!

Related